Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02748525 · ClinicalTrials.gov registry record · Phase 4

Evaluation of Gallbladder Contractility Using Both CCK and Milk Consecutively

A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
Phase 4
Development phase
50
Enrollment target

NCT02748525: Completed Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.

NCT02748525 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 50 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02748525, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
Phase 4
Development phase
50 participants
Enrollment target

Study Summary

This study aims to combine the use of IV CCK administration followed by oral milk during a HIDA scan to further stimulate the gallbladder contractility and decrease the number of false abnormal HIDA scans and unnecessary cholecystectomies in some patients.

Primary Outcome

Patient will receive CCK, be scanned, and the ejection fraction will be measured.

Interventions

  • OTHER Milk
  • BIOLOGICAL CCK

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2016-05-03
Est. Completion 2018-06-14
Phase Phase 4

What the finished NCT02748525 record still lists

NCT02748525 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 2 interventions - of which Milk is the first listed.

NCT02748525 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02748525 about?

NCT02748525 is a clinical study titled "Evaluation of Gallbladder Contractility Using Both CCK and Milk Consecutively". This study aims to combine the use of IV CCK administration followed by oral milk during a HIDA scan to further stimulate the gallbladder contractility and decrease the number of false abnormal HIDA scans and unnecessary cholecystectomies in some patients.

What is the current status of trial NCT02748525?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2016-05-03. Estimated completion is 2018-06-14.

What interventions are being tested in trial NCT02748525?

The interventions under investigation include: Milk (OTHER), CCK (BIOLOGICAL).

Who is sponsoring clinical trial NCT02748525?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02748525's enrollment target sits among peer trials

50 1255th of 2000 higher than 678 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02748525, the US trial registry maintained by the National Library of Medicine. NCT02748525 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.